Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Conditions: Prostate Adenocarcinoma; Radiation Toxicity Interventions: Radiation: External beam radiation therapy, High-dose-rate brachytherapy; Drug: Goserelin 10.8 mg Sponsor: German Oncology Center, Cyprus Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Brachytherapy | Cancer | Cancer & Oncology | Cyprus Health | External Beam Therapy | Prostate Cancer | Radiation Therapy | Research | Toxicology